Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Bourdeau

Showing results (91-100 of 121) with videos related to

Pageof 13
Sort By:
Nucleic Acids Research|June 10, 2022
ARMC5 is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasiaLinjiang Lao, Isabelle Bourdeau, Lucia Gagliardi, et al.
The Journal of Clinical Endocrinology and Metabolism|March 3, 2005
Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical cushing syndrome: a clinical and molecular genetic investigationLudmila Matyakhina, Reneé J Freedman, Isabelle Bourdeau, et al.
Genome Biology|January 15, 2024
ARMC5 controls the degradation of most Pol II subunits, and ARMC5 mutation increases neural tube defect risks in mice and humansHongyu Luo, Linjiang Lao, Kit Sing Au, et al.
The Journal of Clinical Endocrinology and Metabolism|January 20, 2012
Activation of cyclic AMP signaling leads to different pathway alterations in lesions of the adrenal cortex caused by germline PRKAR1A defects versus those due to somatic GNAS mutationsMadson Q Almeida, Monalisa F Azevedo, Paraskevi Xekouki, et al.
British Journal of Cancer|May 21, 2019
A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trialGrainne M O'Kane, Shereen Ezzat, Anthony M Joshua, et al.
Scientific Reports|May 20, 2022
Influence of diet on acute endocannabinoidome mediator levels post exercise in active women, a crossover randomized studyFabiola Forteza, Isabelle Bourdeau-Julien, Guillaume Q Nguyen, et al.
The Journal of Clinical Endocrinology and Metabolism|March 19, 2009
Mutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypesJérôme Bertherat, Anélia Horvath, Lionel Groussin, et al.
JCI Insight|May 22, 2025
Endothelial extracellular vesicle miR-423-5p regulates microvascular homeostasis and renal function after ischemia-reperfusion injuryFrancis Migneault, Hyunyun Kim, Alice Doreille, et al.
Journal of Personalized Medicine|April 30, 2021
What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered QuestionVittoria Basile, Soraya Puglisi, Barbara Altieri, et al.
Endocrine-Related Cancer|April 12, 2023
African American vs Caucasian race/ethnicity in adrenocortical carcinoma patientsAndrea Panunzio, Stefano Tappero, Lukas Hohenhorst, et al.
Pageof 13

Showing results (91-100 of 121) with videos related to

Sort By:
Pageof 13
Nucleic Acids Research|June 10, 2022
ARMC5 is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasiaLinjiang Lao, Isabelle Bourdeau, Lucia Gagliardi, et al.
The Journal of Clinical Endocrinology and Metabolism|March 3, 2005
Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical cushing syndrome: a clinical and molecular genetic investigationLudmila Matyakhina, Reneé J Freedman, Isabelle Bourdeau, et al.
Genome Biology|January 15, 2024
ARMC5 controls the degradation of most Pol II subunits, and ARMC5 mutation increases neural tube defect risks in mice and humansHongyu Luo, Linjiang Lao, Kit Sing Au, et al.
The Journal of Clinical Endocrinology and Metabolism|January 20, 2012
Activation of cyclic AMP signaling leads to different pathway alterations in lesions of the adrenal cortex caused by germline PRKAR1A defects versus those due to somatic GNAS mutationsMadson Q Almeida, Monalisa F Azevedo, Paraskevi Xekouki, et al.
British Journal of Cancer|May 21, 2019
A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trialGrainne M O'Kane, Shereen Ezzat, Anthony M Joshua, et al.
Scientific Reports|May 20, 2022
Influence of diet on acute endocannabinoidome mediator levels post exercise in active women, a crossover randomized studyFabiola Forteza, Isabelle Bourdeau-Julien, Guillaume Q Nguyen, et al.
The Journal of Clinical Endocrinology and Metabolism|March 19, 2009
Mutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypesJérôme Bertherat, Anélia Horvath, Lionel Groussin, et al.
JCI Insight|May 22, 2025
Endothelial extracellular vesicle miR-423-5p regulates microvascular homeostasis and renal function after ischemia-reperfusion injuryFrancis Migneault, Hyunyun Kim, Alice Doreille, et al.
Journal of Personalized Medicine|April 30, 2021
What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered QuestionVittoria Basile, Soraya Puglisi, Barbara Altieri, et al.
Endocrine-Related Cancer|April 12, 2023
African American vs Caucasian race/ethnicity in adrenocortical carcinoma patientsAndrea Panunzio, Stefano Tappero, Lukas Hohenhorst, et al.
Pageof 13